Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 71610-736

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71610-736). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 30 mg (71610 0736 42)

Duloxetine DR, USP is a medication that is available in capsule form. The specific details about the medication, such as its purpose and instructions for use, are not available based on the provided text.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Duloxetine 01)

FDA Label Image

Figure 1 (Duloxetine 02)

This text appears to be a chart showing the proportion of patients with relapse over time. The chart includes data points labeled from 10 to 0, with the corresponding values for the placebo and Dulovetie delayecheleass capeuls treatments. The x-axis represents the time from randomization to relapse in days.*

FDA Label Image

Figure 2 (Duloxetine 03)

FDA Label Image

Figure 3 (Duloxetine 04)

FDA Label Image

Figure 4 (Duloxetine 05)

FDA Label Image

Figure 5 (Duloxetine 06)

FDA Label Image

Figure 6 (Duloxetine 07)

FDA Label Image

Figure 8 (Duloxetine 08)

FDA Label Image

Figure 9 (Duloxetine 09)

FDA Label Image

Figure 10 (Duloxetine 10)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.